Impilo
Overview
Impilo is a Nordic-based private equity firm that invests in healthcare companies, including those in the pharmaceuticals, medical technology, and healthcare services sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Suturion | Dec 2024 | VC Round | Co-investor |
| ArgusEye | Apr 2026 | VC Round | Co-investor |
| ArgusEye AB | Apr 2026 | Early Funding | Co-investor |
| Texray AB | Nov 2023 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Frederik Zimmer
Industrial Partner
Fredrik Strömholm
Partner
Henning Søgaard
Industrial Partner
Jens Bager
Industrial Partner
Peder Walberg
Industrial Partner
Per Edelmann
Industrial Partner
Martin Fagerlund
Partner COO
Alexander From
Senior Investment Manager
Edvard Hubendick
Senior Investment Manager
Emilia Staaf
Investment Manager
Frederikke Beck
Senior Investment Manager
Henrik Nielsen
Senior Investment Manager
Johan Kårestedt
Investment Manager
Matilda Hessedahl
Senior Investment Manager
Olga Court-Payen
Investment Manager
Paula Johansson
Investment Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Impilo based?
Impilo is headquartered in Stockholm, Sweden.
When was Impilo founded?
Impilo was founded in 2017.
How many portfolio companies does Impilo have?
Impilo has 17 portfolio companies in Caplight's dataset.
What are some companies in Impilo's portfolio?
Portfolio companies visible on Caplight include Suturion, ArgusEye, ArgusEye AB, Texray AB.
What was Impilo's most recent investment shown here?
Impilo's most recent investment in this portfolio sample was in ArgusEye in 2026.
What sectors does Impilo focus on?
Impilo focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Impilo focus on?
Impilo typically invests at the MultiStage stage.
What is Impilo's AUM?
Impilo's assets under management are estimated between $2.2B and $2.2B.